Champions Oncology, Inc. (CSBR)
5.82
-0.23
(-3.80%)
USD |
NASDAQ |
Feb 20, 16:00
5.92
+0.10
(+1.72%)
After-Hours: 20:00
Champions Oncology EPS Diluted (Quarterly) : 0.0185 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.237M |
| Revenue (Quarterly) | 15.04M |
| Total Expenses (Quarterly) | 14.77M |
| Enterprise Value | 77.78M |
| Gross Profit Margin (Quarterly) | 49.32% |
| Profit Margin (Quarterly) | 1.58% |
| Earnings Yield | 2.86% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 2.859 |